当前蛋白身份:P04117 重新检索
本组结构的主要差异维度
构建体不同 突变/修饰不同 组装状态不同 配体/离子不同 实验环境不同 结构质量指标不同

差异标签只比较当前检索结果;所有PDB和assembly原始记录仍分别保留。

相关结构差异明细

一行代表一个 PDB 条目中的一个 biological assembly;同一蛋白的多个单体会分别列出。

PDB 条目 Assembly / 聚集状态 构建体 突变与修饰 配体、离子与非聚合物 实验方法 实验环境 结构质量
1A18 PHENANTHROLINE MODIFIED MURINE ADIPOCYTE LIPID BINDING PROTEIN 提交 1997-12-23 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–131(131 aa)
非标准单体:是(mmCIF未提供具体位点) 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;pH 6.5
分辨率 2.40 Å R-free 0.273
1A2D PYRIDOXAMINE MODIFIED MURINE ADIPOCYTE LIPID BINDING PROTEIN 提交 1997-12-29 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–131(131 aa)
链 B 1–131(131 aa)
非标准单体:是(mmCIF未提供具体位点) 非标准单体:是(mmCIF未提供具体位点) CL CHLORIDE ION × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.5;pH 6.5
分辨率 2.40 Å R-free 0.273
1AB0 C1G/V32D/F57H MUTANT OF MURINE ADIPOCYTE LIPID BINDING PROTEIN AT PH 4.5 提交 1997-01-30 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–131(130 aa)
突变:C1G, V32D, F57H 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 pH 4.5;2.4M AMSO4 50MM NAKPO4 100 MM ACETATE, PH 4.5
分辨率 1.90 Å R-free 0.253
1ACD V32D/F57H MUTANT OF MURINE ADIPOCYTE LIPID BINDING PROTEIN 提交 1997-02-06 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–131(130 aa)
突变:C1G, V32D, F57H 非标准单体:是(mmCIF未提供具体位点) 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 pH 6.4;2.4M PHOSPHATE, PH 6.4
分辨率 2.70 Å R-free 0.276
1ADL ADIPOCYTE LIPID BINDING PROTEIN COMPLEXED WITH ARACHIDONIC ACID: X-RAY CRYSTALLOGRAPHIC AND TITRATION CALORIMETRY STUDIES 提交 1994-03-25 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–132(131 aa)
非标准单体:是(mmCIF未提供具体位点) ACD ARACHIDONIC ACID × 2 PPI PROPANOIC ACID × 2 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 1.60 Å R-free 0.220
1ALB CRYSTAL STRUCTURE OF RECOMBINANT MURINE ADIPOCYTE LIPID-BINDING PROTEIN 提交 1992-09-03 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–131(131 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 2.50 Å
1G74 Toward changing specificity: adipocyte lipid binding protein mutant, oleic acid bound form 提交 2000-11-08 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–131(131 aa)
突变:I73E,A75V,D77G PO4 PHOSPHATE ION × 1 OLA OLEIC ACID × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.8;291 K;sodium/potassium phosphate, pH 6.8, VAPOR DIFFUSION, HANGING DROP, temperature 291K
分辨率 1.70 Å R-free 0.238
1G7N Toward changing specificity: adipocyte lipid binding protein mutant, apo form 提交 2000-11-10 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–131(131 aa)
突变:I73E,A75V,D77G PO4 PHOSPHATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 7;291 K;sodium/potassium phosphate, pH 7.0, VAPOR DIFFUSION, HANGING DROP, temperature 291K
分辨率 1.50 Å R-free 0.225
1LIB THE ADIPOCYTE LIPID-BINDING PROTEIN AT 1.6 ANGSTROMS RESOLUTION: CRYSTAL STRUCTURES OF THE APOPROTEIN AND WITH BOUND SATURATED AND UNSATURATED FATTY ACIDS 提交 1993-12-21 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–131(131 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 1.70 Å
1LIC X-RAY CRYSTALLOGRAPHIC STRUCTURES OF ADIPOCYTE LIPID BINDING PROTEIN COMPLEXED WITH PALMITATE AND HEXADECANESULFONIC ACID. PROPERTIES OF CAVITY BINDING SITES. 提交 1993-12-21 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–131(131 aa)
非标准单体:是(mmCIF未提供具体位点) HDS 1-HEXADECANOSULFONIC ACID × 2 PPI PROPANOIC ACID × 2 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 1.60 Å R-free 0.225
1LID THE ADIPOCYTE LIPID-BINDING PROTEIN AT 1.6 ANGSTROMS RESOLUTION: CRYSTAL STRUCTURES OF THE APOPROTEIN AND WITH BOUND SATURATED AND UNSATURATED FATTY ACIDS 提交 1993-12-21 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–131(131 aa)
未记录 OLA OLEIC ACID × 2 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 1.60 Å
1LIE X-RAY CRYSTALLOGRAPHIC STRUCTURES OF ADIPOCYTE LIPID BINDING PROTEIN COMPLEXED WITH PALMITATE AND HEXADECANESULFONIC ACID. PROPERTIES OF CAVITY BINDING SITES 提交 1993-12-21 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–131(131 aa)
非标准单体:是(mmCIF未提供具体位点) PLM PALMITIC ACID × 2 PPI PROPANOIC ACID × 2 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 1.60 Å R-free 0.239
1LIF THE ADIPOCYTE LIPID-BINDING PROTEIN AT 1.6 ANGSTROMS RESOLUTION: CRYSTAL STRUCTURES OF THE APOPROTEIN AND WITH BOUND SATURATED AND UNSATURATED FATTY ACIDS 提交 1993-12-21 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–131(131 aa)
未记录 STE STEARIC ACID × 2 X-RAY DIFFRACTION mmCIF 未提供已读取条件 分辨率 1.60 Å
2ANS ADIPOCYTE LIPID BINDING PROTEIN COMPLEXED WITH 1-ANILINO-8-NAPHTHALENE SULFONATE 提交 1999-01-19 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–131(131 aa)
链 B 1–131(131 aa)
未记录 CL CHLORIDE ION × 1 2AN 8-ANILINO-1-NAPHTHALENE SULFONATE × 2 X-RAY DIFFRACTION
X-ray结晶条件 pH 7.5;pH 7.5
分辨率 2.50 Å R-free 0.247
2Q9S Linoleic Acid Bound to Fatty Acid Binding Protein 4 提交 2007-06-13 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–132(132 aa)
未记录 SO4 SULFATE ION × 2 EIC LINOLEIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M Sodium Cacodylate, 0.1 M Ammonium Sulfate, 35% PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.30 Å R-free 0.264
2Q9S Linoleic Acid Bound to Fatty Acid Binding Protein 4 提交 2007-06-13 Assembly 2 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–132(132 aa)
未记录 SO4 SULFATE ION × 2 EIC LINOLEIC ACID × 2 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, HANGING DROP;pH 6.5;293 K;0.1 M Sodium Cacodylate, 0.1 M Ammonium Sulfate, 35% PEG 8000, pH 6.5, VAPOR DIFFUSION, HANGING DROP, temperature 293K
分辨率 2.30 Å R-free 0.264
2QM9 Troglitazone Bound to Fatty Acid Binding Protein 4 提交 2007-07-14 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 1–132(132 aa)
链 B 1–132(132 aa)
未记录 SO4 SULFATE ION × 3 TDZ (5R)-5-(4-{[(2R)-6-HYDROXY-2,5,7,8-TETRAMETHYL-3,4-DIHYDRO-2H-CHROMEN-2-YL]METHOXY}BENZYL)-1,3-THIAZOLIDINE-2,4-DIONE × 2 X-RAY DIFFRACTION
X-ray结晶条件 hanging drop;pH 4.5;298 K;1.6 M ammonium sulfate, 0.1 M sodium acetate, 0.05 M K/Na phosphate, pH 4.5, hanging drop, temperature 298K
分辨率 2.31 Å R-free 0.276
3HK1 Identification and Characterization of a Small Molecule Inhibitor of Fatty Acid Binding Proteins 提交 2009-05-22 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 2–132(131 aa)
未记录 B64 4-{[2-(methoxycarbonyl)-5-(2-thienyl)-3-thienyl]amino}-4-oxo-2-butenoic acid × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;291 K;2.5 M sodium/potassium phosphate, pH 7.0, VAPOR DIFFUSION, SITTING DROP, temperature 291K
分辨率 1.70 Å R-free 0.195
3JS1 Crystal structure of adipocyte fatty acid binding protein covalently modified with 4-hydroxy-2-nonenal 提交 2009-09-09 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–132(131 aa)
链 B 2–132(131 aa)
非标准单体:是(mmCIF未提供具体位点) 非标准单体:是(mmCIF未提供具体位点) PO4 PHOSPHATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;291 K;1.9 M Sodium/potassium phosphate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
分辨率 1.81 Å R-free 0.228
3JSQ Crystal structure of adipocyte fatty acid binding protein non-covalently modified with 4-hydroxy-2-nonenal 提交 2009-09-10 Assembly 1 蛋白同源多聚体 同源多聚体;蛋白 × 2 PDB 声明:dimeric(2) 与蛋白数一致
链 A 2–132(131 aa)
未记录 CL CHLORIDE ION × 2 HNE (2E,4R)-4-HYDROXYNON-2-ENAL × 2 PO4 PHOSPHATE ION × 8 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7.5;291 K;0.1 M HEPES, 1.6 M Sodium/potassium phosphate, pH 7.5, VAPOR DIFFUSION, SITTING DROP, temperature 291K
分辨率 2.30 Å R-free 0.263
5C0N Development of a monoclonal antibody targeting secreted aP2 to treat diabetes and fatty liver disease 提交 2015-06-12 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 1–132(132 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;296 K;0.1M Hepes pH 7.5, 0.2M NH2SO4, 16% PEG 4K and 10% isopropanol
分辨率 3.00 Å R-free 0.265
5C0N Development of a monoclonal antibody targeting secreted aP2 to treat diabetes and fatty liver disease 提交 2015-06-12 Assembly 2 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 B 1–132(132 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;296 K;0.1M Hepes pH 7.5, 0.2M NH2SO4, 16% PEG 4K and 10% isopropanol
分辨率 3.00 Å R-free 0.265
5D8J Development of a therapeutic monoclonal antibody targeting secreted aP2 to treat type 2 diabetes. 提交 2015-08-17 Assembly 1 蛋白异源复合物 异源复合物;蛋白 × 3 PDB 声明:trimeric(3) 与蛋白数一致
链 A 1–132(132 aa)
未记录 SO4 SULFATE ION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 5.5;296 K;100mM 2-(N-morpholino)ethanesulfonic acid, 150mM ammonium sulfate, 24% PEG 4000
分辨率 3.00 Å R-free 0.269
7FWT Crystal Structure of apo mouse FABP4 提交 2023-04-27 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–132(132 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;protein in 25mM Tris/HCl pH 7.5 100mM NaCl, see also PMID 27658368
分辨率 1.54 Å R-free 0.197
7FWT Crystal Structure of apo mouse FABP4 提交 2023-04-27 Assembly 2 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 B 1–132(132 aa)
未记录 未记录非水小分子 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;protein in 25mM Tris/HCl pH 7.5 100mM NaCl, see also PMID 27658368
分辨率 1.54 Å R-free 0.197
7FZG Crystal Structure of apo mouse FABP4, C-centered orthorhombic form 提交 2023-04-27 Assembly 1 蛋白单体 单体;蛋白 × 1 PDB 声明:monomeric(1) 与蛋白数一致
链 A 1–132(132 aa)
未记录 FLC CITRATE ANION × 1 X-RAY DIFFRACTION
X-ray结晶条件 VAPOR DIFFUSION, SITTING DROP;pH 7;293 K;protein in 25mM Tris/HCl pH 7.5 100mM NaCl, see also PMID 27658368
分辨率 1.49 Å R-free 0.170